CME Group Inc. (NASDAQ:CME) Shares Sold by Prio Wealth Limited Partnership

Prio Wealth Limited Partnership lessened its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 68,120 shares of the financial services provider’s stock after selling 2,672 shares during the period. Prio Wealth Limited Partnership’s holdings in CME Group were worth $15,031,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Oak Harvest Investment Services raised its position in shares of CME Group by 66.5% during the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in CME Group by 21.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares during the period. Duality Advisers LP acquired a new position in CME Group during the first quarter worth approximately $1,455,000. SG Americas Securities LLC increased its position in CME Group by 312.2% during the first quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after buying an additional 42,996 shares during the period. Finally, Cetera Investment Advisers increased its position in CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after buying an additional 38,540 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms have commented on CME. Morgan Stanley lifted their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Finally, Oppenheimer lifted their target price on CME Group from $228.00 to $245.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $220.07.

CME Group Price Performance

CME traded down $1.53 during trading on Monday, reaching $226.79. 117,639 shares of the stock were exchanged, compared to its average volume of 1,932,961. The business’s 50 day moving average price is $216.92 and its two-hundred day moving average price is $208.32. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $81.66 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.12.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.30 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. CME Group’s payout ratio is 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.